Health Encyclopedia

Central serous choroidopathy

Definition

Central serous choroidopathy is a disease that causes fluid to build up under the retina, the part of the eye that sends sight information to the brain. The fluid leaks from the blood vessel layer under the retina. This area is called the choroid.

Alternative Names

Central serous retinopathy

Causes, incidence, and risk factors

The cause of this condition is unknown. Most patients are young men with aggressive, "type A" personalities, but anyone can be affected.

Stress appears to be a risk factor. The condition can also occur as a complication of steroid drug use.

Symptoms

Dim and blurred blind spot in the center of vision
Distortion of straight lines with the affected eye
Objects appearing smaller or farther away with the affected eye

Signs and tests

Your health care provider can usually diagnose central serous choroidopathy by dilating the eye and performing an eye exam. Fluorescein angiography confirms the diagnosis.

Treatment

Most cases clear up without treatment in 1 or 2 months. Patients with more severe leakage and more severe visual loss, or those in whom the disease lasts longer, may be helped by laser treatment to seal the leak.

Patients who are using steroid drugs (for example, to treat autoimmune diseases) should discontinue their use if possible. Any change in steroid drug use in these conditions MUST be under the supervision of a physician.

Expectations (prognosis)

Most patients recover good vision without treatment. The disease returns in about half of all patients, and has a similarly good outlook. Rarely, patients develop permanent scars that damage their central vision.

Complications

A small number of patients will have complications of laser treatment that impair central vision. That is why most patients will be allowed to recover without treatment.

Calling your health care provider

Call your health care provider if visual symptoms worsen.

Prevention

There is no known prevention. Although there is a clear association with stress, there is no evidence that tranquilizer drugs have any benefit in preventing or treating central serous choroidopathy.

Review Date:8/22/2008
Reviewed By:Paul B. Griggs, MD, Department of Ophthalmology, Virginia Mason Medical Center, Seattle, WA. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

ADAM Quality A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.

Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.